Patent Law Weblog
recent posts
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
about
Category: Biotech/Pharma News
-
By Donald Zuhn — The New York Times reported late last week that President Obama will satisfy one of his campaign pledges on Monday when he reverses limits imposed by the Bush administration on embryonic stem cell research. In August of 2001, the Bush administration ordered that federal research be limited to lines of…
-
By Donald Zuhn — Last week, we reviewed prior Patent Docs reports discussing some aspects of President-elect Barack Obama's technology platform, including his positions on patent issues and follow-on biologics (see "A Second Look at President-elect Obama's Technology Platform"). We also reported on the response by some in the patent community to last week's…
-
By Donald Zuhn — Patents Online, LLC, the company behind FreePatentsOnline, today announced the release of a companion online service, SumoBrain. The service, which was launched this summer, offers an alternative to patent search pay services by providing free cross-collection searching, portfolios, saved search capabilities, alerts, bulk PDF download capabilities, and collaboration tools. …
-
By Donald Zuhn — The U.S. Patent and Trademark Office announced today that U.S. Secretary of Commerce Carlos Gutierrez joined President Bush last week in identifying the winners of the 2007 National Medal of Technology and Innovation. The award, previously known as the National Medal of Technology, is the highest honor that the…
-
By Christopher P. Singer — In a July 29, 2008 presentation at the Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD 2008) in Chicago, scientists involved in a collaboration between the University of Aberdeen and TauRx Therapeutics discussed data demonstrating that their candidate drug, rember, appears to slow the progress of the Alzheimer’s…
-
By Kevin E. Noonan — One of the promises of the genomics revolution of the late 20th Century is the advent of personalized medicine. The belief was (and is) that the unfolding understanding of genetic variation stemming from sequence analysis of genes known or discovered to be involved in an individual’s response to…
-
By Kevin E. Noonan — Steven Burrill, President and CEO of Burrill & Co., unveiled his company’s "State of the Biotechnology Industry" report on Wednesday at BIO 2008 in San Diego. Mr. Burrill (below) described developments globally that he anticipates will occur by 2020 and how those changes will impact the industry. Mr.…
-
By Kevin E. Noonan — The current crises in energy and food have followed eerily similar paths. The founding of OPEC and the exponential rise in crude oil prices during and after the 1973 Arab-Israeli conflict produced a short-lived emphasis in the U.S. with fuel efficiency and smaller automobiles. These were predominantly imported…
-
By Donald Zuhn — Dr. Michael Wisz, the Chief Technical Officer of Emerjent, Inc., recently contacted Patent Docs to inform us about Espresso, a new web-based search application that Emerjent is touting as "the premier emerging technology information search engine." The search engine, which requires a free registration to access, can be found…
-
By Kevin E. Noonan — American opinion has finally turned in support of the idea that global warming, and ecological concerns in general, are relevant and important to themselves and their children (despite years of opposition, both formal and informal, from the current Administration and its fellow-travelers from energy corporations and the right…
Patent Docs 